GrandOmics

About:

Grandomics provides molecular diagnosis, research, and carrier screening for single gene diseases.

Top Investors: Matrix Partners China, SAIF Partners, Zero2IPO Ventures, Zero2IPO, Marathon Venture Partners

Description:

Grandomics provides molecular diagnosis, research, and carrier screening for single gene diseases. It also produces comprehensive, scientific, and accurate genetic testing services. Grandomics developes GrandBoxTM, a set of computing software, clinical sample management, data standard analysis and visualization analysis report. It provides one station for clinical laboratories Based genetic disease sequencing data management and analysis platform.

Total Funding Amount:

$29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Changping, Beijing, China

Founded Date:

2015-01-01

Contact Email:

Support(AT)grandomics.com

Founders:

Depeng Wang, Kai Wang

Number of Employees:

11-50

Last Funding Date:

2018-07-02

IPO Status:

Private

Industries: